Australia, July 18 -- Australia based CSL Behring (Australia) Pty Ltd has secured contract from National Blood Authority for Procurement of Imported Plasma and Recombinant Products (IPRP) - Idelvion. The value of the contract is worth 73,601,832.70 AUD.
Published by HT Digital Content Services with permission from Pivotal Sources....